BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2421440)

  • 1. Reoperation for prosthetic heart valve replacement.
    de Bruin MJ; Lacquet LK; Skotnicki SH; Vincent JG; van der Meer JJ
    Thorac Cardiovasc Surg; 1986 Feb; 34(1):12-6. PubMed ID: 2421440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late prognosis after reoperation for prosthetic valve replacement.
    Bosch X; Pomar JL; Pelletier LC
    J Thorac Cardiovasc Surg; 1984 Oct; 88(4):567-72. PubMed ID: 6482488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late results of heart valve replacement with the Hancock II bioprosthesis.
    David TE; Ivanov J; Armstrong S; Feindel CM; Cohen G
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):268-77. PubMed ID: 11174732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricuspid valve replacement: bioprostheses are preferable.
    Dalrymple-Hay MJ; Leung Y; Ohri SK; Haw MP; Ross JK; Livesey SA; Monro JL
    J Heart Valve Dis; 1999 Nov; 8(6):644-8. PubMed ID: 10616242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac valve reoperations: analysis of operative risk factors in 154 patients.
    Beghi C; De Cicco G; Nicolini F; Ballore L; Reverberi C; Gherli T
    J Heart Valve Dis; 2002 Mar; 11(2):258-62. PubMed ID: 12000169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early mechanical failures of the Hancock pericardial xenograft.
    Bortolotti U; Milano A; Thiene G; Guerra F; Mazzucco A; Valente M; Talenti E; Gallucci V
    J Thorac Cardiovasc Surg; 1987 Aug; 94(2):200-7. PubMed ID: 3613618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Carpentier-Edwards standard porcine bioprosthesis. A first-generation tissue valve with excellent long-term clinical performance.
    Jamieson WR; Allen P; Miyagishima RT; Gerein AN; Munro AI; Burr LH; Tyers GF
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):543-61. PubMed ID: 2308373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
    Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reoperation on prosthetic heart valves. An analysis of risk factors in 552 patients.
    Husebye DG; Pluth JR; Piehler JM; Schaff HV; Orszulak TA; Puga FJ; Danielson GK
    J Thorac Cardiovasc Surg; 1983 Oct; 86(4):543-52. PubMed ID: 6621082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?
    Alsoufi B; Manlhiot C; McCrindle BW; Canver CC; Sallehuddin A; Al-Oufi S; Joufan M; Al-Halees Z
    Eur J Cardiothorac Surg; 2009 Jul; 36(1):84-90; discussion 90. PubMed ID: 19369085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eighteen-year follow up after Hancock II bioprosthesis insertion.
    Legarra JJ; Llorens R; Catalan M; Segura I; Trenor AM; de Buruaga JS; Rabago G; Sarralde A
    J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous aortic and mitral valve replacement: predictors of adverse outcome.
    Kuwaki K; Tsukamoto M; Komatsu K; Morishita K; Sakata J; Abe T
    J Heart Valve Dis; 2003 Mar; 12(2):169-76. PubMed ID: 12701788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent durability of the Hancock porcine bioprosthesis in the tricuspid position. A sixteen-year follow-up study.
    Kawachi Y; Tominaga R; Hisahara M; Nakashima A; Yasui H; Tokunaga K
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1561-6. PubMed ID: 1453721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The St. Jude Medical bileaflet valve prosthesis. A 5 year experience.
    Chaux A; Czer LS; Matloff JM; DeRobertis MA; Stewart ME; Bateman TM; Kass RM; Lee ME; Gray RJ
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):706-17. PubMed ID: 6492839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-year experience with the St Jude Medical mechanical valve prosthesis.
    Ikonomidis JS; Kratz JM; Crumbley AJ; Stroud MR; Bradley SM; Sade RM; Crawford FA
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2022-31. PubMed ID: 14688722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
    Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prosthetic valve endocarditis: surgical procedures and clinical outcome.
    Otaki M
    Cardiovasc Surg; 1994 Apr; 2(2):212-5. PubMed ID: 8049948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term follow-up of aortic or mitral valve replacement. Comparison of results following implantation of a mechanical or biological artificial valve].
    Mudra H; Rudolph W
    Herz; 1986 Apr; 11(2):97-115. PubMed ID: 3699678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.